Cost-effectiveness in the treatment of schizophrenia

Martin Knapp (1996)

Please note: this is a legacy publication from CPEC (formely PSSRU at LSE).

European Psychiatry 11 2 137-143

https://doi.org/10.1016/0924-9338(96)85179-0

Abstract

This paper discusses the need for a health economics perspective and some of the central methodological issues raised by economic appraisals, including cost-effectiveness and cost-utility analyses. It illustrates how cost-effectiveness studies can info